These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7871545)

  • 1. Polychlorinated biphenyl-induced suppression of cytotoxic T lymphocyte activity: role of prostaglandin-E2.
    De Krey GK; Baecher-Steppan L; Fowles JR; Kerkvliet NI
    Toxicol Lett; 1994 Dec; 74(3):211-20. PubMed ID: 7871545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen.
    De Krey GK; Baecher-Steppan L; Deyo JA; Smith B; Kerkvliet NI
    J Pharmacol Exp Ther; 1993 Oct; 267(1):308-15. PubMed ID: 8229756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of allograft immunity by 3,4,5,3',4',5'-hexachlorobiphenyl. I. Effects of exposure on tumor rejection and cytotoxic T cell activity in vivo.
    Kerkvliet NI; Baecher-Steppan L
    Immunopharmacology; 1988; 16(1):1-12. PubMed ID: 3139583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of prolactin and cytotoxic T-lymphocyte activity in PCB-treated mice.
    De Krey GK; Hollingshead NC; Kerkvliet NI; Smith BB
    Int J Immunopharmacol; 1994 Mar; 16(3):251-7. PubMed ID: 8206692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of allograft immunity by 3,4,5,3',4',5'-hexachlorobiphenyl. II. Effects of exposure on mixed lymphocyte reactivity and induction of suppressor cell activity in vitro.
    Kerkvliet NI; Baecher-Steppan L
    Immunopharmacology; 1988; 16(1):13-23. PubMed ID: 2971633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Ah locus in suppression of cytotoxic T lymphocyte activity by halogenated aromatic hydrocarbons (PCBs and TCDD): structure-activity relationships and effects in C57Bl/6 mice congenic at the Ah locus.
    Kerkvliet NI; Baecher-Steppan L; Smith BB; Youngberg JA; Henderson MC; Buhler DR
    Fundam Appl Toxicol; 1990 Apr; 14(3):532-41. PubMed ID: 2111257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of altered arachidonic acid metabolism in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice.
    Lawrence BP; Kerkvliet NI
    Toxicol Sci; 1998 Mar; 42(1):13-22. PubMed ID: 9538043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of cytotoxic responses by prostaglandin E2.
    Häcker-Shahin B; Dröge W
    Cell Immunol; 1985 Mar; 91(1):43-51. PubMed ID: 3871666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice.
    Kuroda E; Sugiura T; Zeki K; Yoshida Y; Yamashita U
    J Immunol; 2000 Mar; 164(5):2386-95. PubMed ID: 10679074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prostaglandins and indomethacin on cytotoxic T-lymphocytes and their precursors.
    Skinner M; Skinner S; Marbrook J
    Int J Immunopharmacol; 1989; 11(3):267-73. PubMed ID: 2786858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification by biological products of the generation of suppressor cells in culture.
    Leung KH; Ehrke MJ; Mihich E
    Immunopharmacology; 1983 Feb; 5(3):221-37. PubMed ID: 6219969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2.
    Okada F; Hosokawa M; Hasegawa J; Ishikawa M; Chiba I; Nakamura Y; Kobayashi H
    Cancer Immunol Immunother; 1990; 31(6):358-64. PubMed ID: 2386981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cytotoxic T lymphocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin occurs in vivo, but not in vitro, and is independent of corticosterone elevation.
    De Krey GK; Kerkvliet NI
    Toxicology; 1995 Mar; 97(1-3):105-12. PubMed ID: 7716775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of macrophagic prostaglandin E2 synthesis by glioma cells.
    Nakano Y; Kuroda E; Kito T; Yokota A; Yamashita U
    J Neurosurg; 2006 Apr; 104(4):574-82. PubMed ID: 16619662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC; Hargrove ME
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.